Department of Biotechnology, Institute of Chemical Technology, Technická 5, 166 28 Prague, Czech Republic.
Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., IOCB & Gilead Research Center, Flemingovo nám. 2, 166 10 Prague, Czech Republic.
J Gen Virol. 2014 Jun;95(Pt 6):1383-1389. doi: 10.1099/vir.0.064345-0. Epub 2014 Mar 21.
We identified breast cancer-associated protein (BCA3) as a novel binding partner of Mason-Pfizer monkey virus (MPMV) protease (PR). The interaction was confirmed by co-immunoprecipitation and immunocolocalization of MPMV PR and BCA3. Full-length but not C-terminally truncated BCA3 was incorporated into MPMV virions. We ruled out the potential role of the G-patch domain, a glycine-rich domain located at the C terminus of MPMV PR, in BCA3 interaction and virion incorporation. Expression of BCA3 did not affect MPMV particle release and proteolytic processing; however, it slightly increased MPMV infectivity.
我们鉴定出乳腺癌相关蛋白(BCA3)是猴 Mason-Pfizer 病毒(MPMV)蛋白酶(PR)的一个新的结合伴侣。MPMV PR 和 BCA3 的共免疫沉淀和免疫共定位证实了这种相互作用。全长而非 C 端截断的 BCA3 被掺入 MPMV 病毒粒子中。我们排除了 G 补丁结构域(位于 MPMV PR C 端的富含甘氨酸的结构域)在 BCA3 相互作用和病毒粒子掺入中的潜在作用。BCA3 的表达并不影响 MPMV 颗粒释放和蛋白水解加工;然而,它略微增加了 MPMV 的感染性。